U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells
Open Access
- 1 December 2002
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 277 (49), 47366-47372
- https://doi.org/10.1074/jbc.m208284200
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Molecular interpretation of ERK signal duration by immediate early gene productsNature, 2002
- Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)Journal of Biological Chemistry, 2000
- Receptor activator of NF‐κB recruits multiple TRAF family adaptors and activates c‐Jun N‐terminal kinaseFEBS Letters, 1999
- RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in OsteoclastogenesisBiochemical and Biophysical Research Communications, 1998
- Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human OsteoclastsPublished by Elsevier BV ,1996
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Molecular Cloning of Human cDNA for Cathepsin K: Novel Cysteine Proteinase Predominantly Expressed in BoneBiochemical and Biophysical Research Communications, 1995
- EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptorCurrent Biology, 1994
- Growth factor‐stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1)FEBS Letters, 1994
- Osteoclasts express high levels of pp60c-src in association with intracellular membranes.The Journal of cell biology, 1992